Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report
LEXINGTON, Mass. — Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will release its third quarter 2025 financial results before the market opens on Monday, November 10, 2025. The company also plans to host
(Financial Post, 2025-11-05T18:49:56Z)